Literature DB >> 10815012

Antiproliferative effects of compounds derived from plants of Northeast Brazil.

C Pessoa1, E R Silveira, T L Lemos, L A Wetmore, M O Moraes, A Leyva.   

Abstract

Ten compounds derived from plants indigenous to Northeast Brazil were examined for antiproliferative effects on human cells in vitro. The effects of these phytochemicals on cell growth were determined by the MTT microtitre assay with 3-day continuous drug exposure. Three human cell lines were used: CEM leukaemia, SW1573 lung tumour and CCD922 normal skin fibroblasts. Four active compounds were found with IC(50) values less than 10 microg/mL in the two cancer cell lines. Oncocalyxones A and C, both 1,4-anthracenediones from Auxemma oncocalyx (Boraginaceae), showed cytotoxicity with mean IC(50) values of 0.8-2, 7-8 and 12-13 microg/mL against CEM, SW1573 and CCD922, respectively. One diterpene and one flavonoid, both from Egletes viscosa (Compositae), were also active. 12-Acetoxy-hawtriwaic acid lactone was cytotoxic with mean IC(50) values of 6, 10 and 10 microg/mL, respectively. 4,5-Dihydroxy-3,3,7, 8-tetramethoxy flavone (ternatin) was only growth-inhibitory with mean IC(50) values of 2, 1 and 10 microg/mL, respectively. These four most active compounds were examined further for their effects on DNA integrity and on DNA synthesis. All but ternatin caused substantial DNA damage and marked inhibition of 5-bromo-2'-deoxyuridine incorporation within 24 h. This study demonstrated the antiproliferative activity of four novel phytochemicals, three of which are DNA-reactive and inhibit DNA synthesis. Further studies are warranted to evaluate these compounds for antitumour potential. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10815012     DOI: 10.1002/(sici)1099-1573(200005)14:3<187::aid-ptr572>3.0.co;2-i

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  4 in total

1.  Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.

Authors:  M A D Ferreira; N R F do Nascimento; C M de Sousa; O D L Pessoa; T L G de Lemos; J S Ventura; M Schattner; A M Chudzinski-Tavassi
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

2.  Magnetic nanosystem for cancer therapy using oncocalyxone a, an antitomour secondary metabolite isolated from a Brazilian plant.

Authors:  Antônio C H Barreto; Vivian R Santiago; Rafael M Freire; Selma E Mazzetto; Juliano C Denardin; Giuseppe Mele; Igor M Cavalcante; Maria E N P Ribeiro; Nágila M P S Ricardo; Tamara Gonçalves; Luigi Carbone; Telma L G Lemos; Otília D L Pessoa; Pierre B A Fechine
Journal:  Int J Mol Sci       Date:  2013-09-05       Impact factor: 5.923

3.  Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids.

Authors:  Katrin Sak; Hele Everaus
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

Review 4.  Repurposing anticancer drugs for the management of COVID-19.

Authors:  Khalid El Bairi; Dario Trapani; Angelica Petrillo; Cécile Le Page; Hanaa Zbakh; Bruno Daniele; Rhizlane Belbaraka; Giuseppe Curigliano; Said Afqir
Journal:  Eur J Cancer       Date:  2020-09-22       Impact factor: 9.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.